Balance Sheet Data
Titan Pharmaceuticals, Inc. (TTNP)
$0.7623
-0.02 (-2.27%)
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Total Cash | 7.52 | 9.29 | 5.22 | 5.41 | 6.04 | 97.82 | 727.75 | 5,414.27 | 40,281.01 | 299,681.95 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 0.06 | 1.84 | 0.99 | 0.88 | 0.11 | 2.60 | 19.33 | 143.78 | 1,069.71 | 7,958.43 |
| Account Receivables (%) | ||||||||||
| Inventories | - | 1.26 | 1 | 0.33 | 0.29 | 2.13 | 15.83 | 117.77 | 876.22 | 6,518.86 |
| Inventories (%) | ||||||||||
| Accounts Payable | 0.82 | 1.53 | 1.40 | 1.25 | 0.80 | 11.91 | 88.60 | 659.15 | 4,903.96 | 36,484.41 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.18 | -0.42 | -0.26 | -0.54 | -0.02 | -2.46 | -18.28 | -135.97 | -1,011.62 | -7,526.25 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.